| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | -0.019 | 0.9 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | 0.0059 | 0.9 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | 0.0055 | 0.9 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.9 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.031 | 0.9 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.0046 | 0.9 |